{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:54:52Z","timestamp":1790391292284,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyze the phenotype and genotype of patients with congenital hypopituitarism (CH) and pathogenic (P) GLI2 variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A large cohort of patients with hypopituitarism was screened for GLI2 variants using a next-generation sequencing panel. Genotype\u2013phenotype correlations were then assessed using GENHYPOPIT phenotypic data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 39 GLI2 variants identified in 717 index cases, 17 were classified as pathogenic and likely pathogenic. All these GLI2 variants were identified in 23 patients (17 index cases and 6 relatives) with associated pituitary stalk interruption syndrome or extrapituitary manifestations. GLI2 variants were the most frequently identified genetic cause in patients with syndromic hypopituitarism (68%): 88% (15\/17) of mutations were truncating variants, and 45% were de novo. Most patients with a GLI2 variant (21\/23, 91%) had hypopituitarism, including 21.7% (5\/23) presenting isolated growth hormone deficiency. Two patients had Kallmann syndrome. Pituitary morphological abnormalities were present in 84% of the patients with P GLI2 variants (index cases and affected relatives). The remaining signs included neurocognitive disorders (38%), hexadactyly (27%), cardiac septal defects, and renal\/vesical abnormalities. A possible digenic origin (GLI2\/HESX1) is proposed in one family.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large multicentric international cohort, GLI2 was the most frequently identified genetic cause of syndromic CH with constant association of pituitary stalk interruption syndrome or extrapituitary clinical features. In addition to polydactyly and neurocognitive disorders, cardiac and renal abnormalities were also frequently observed and should be investigated further. The variable expression of GLI2-associated phenotypes justifies further research in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf015","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T19:05:27Z","timestamp":1739387127000},"page":"110-118","source":"Crossref","is-referenced-by-count":11,"title":["Phenotype and genotype of 23 patients with hypopituitarism and pathogenic\n                    <i>GLI2<\/i>\n                    variants"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5550-9636","authenticated-orcid":false,"given":"Karine","family":"Aouchiche","sequence":"first","affiliation":[{"name":"Department of Pediatrics Endocrinology, CHU Timone Enfants, Assistance Publique-H\u00f4pitaux de Marseille (APHM) , 13385 Marseille ,","place":["France"]},{"name":"Aix Marseille University, INSERM, MMG, UMR 1251 , 13385 Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Charmensat","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Endocrinology, CHU Timone Enfants, Assistance Publique-H\u00f4pitaux de Marseille (APHM) , 13385 Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertuit","family":"Morgane","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology GEnOP\u00e9, Assistance-Publique des H\u00f4pitaux de Marseille (AP-HM), H\u00f4pital de la Timone , 13385 Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Teinturier","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Diabetes, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Endocrinology and Diabetes for Children, Bic\u00eatre Paris Sud Hospital (HUPS) , 94270 Le Kremlin-Bic\u00eatre, Val-de-Marne ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Bretones","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Hopital M\u00e8re Enfant, Hospices Civils de Lyon (HCL) , 69500 Bron ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6453-8326","authenticated-orcid":false,"given":"Aude","family":"Brac de la Perriere","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Groupement Hospitalier Est, Hospices Civils de Lyon (HCL) , 69500 Bron ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Layet","sequence":"additional","affiliation":[{"name":"Department of Genetics, Havre's Hospital , 76600 Le Havre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Bouhours-Nouet","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers , 49933 Angers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology, Metabolism, University Hospital of Lille , 59037 Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Haine","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of Nice-Lenval Hospital , 06200 Nice ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Nunes-Sanchez","sequence":"additional","affiliation":[{"name":"Department Endocrinology, University Hospital of Bordeaux , 33604 Pessac ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Camard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Niort Hospital , 79021 Niort ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Baron","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Diabetology, University Hospital of Nantes , 44093 Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-8800","authenticated-orcid":false,"given":"Frederic","family":"Castinetti","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, APHM, Aix Marseille Univ, INSERM, MMG, MarMaRa Institute, UMR 1251, La Conception University Hospital , 13385 Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-6173","authenticated-orcid":false,"given":"Anne","family":"Barlier","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, APHM, Aix Marseille Univ, INSERM, MMG, MarMaRa Institute, UMR 1251, La Conception University Hospital , 13385 Marseille ,","place":["France"]},{"name":"Laboratory of Mol\u00e9cular Biology GenOp\u00e9, APHM, Aix Marseille Univ, INSERM, MMG, IUMR 1251, La Timone University Hospital , 13385 Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-6691","authenticated-orcid":false,"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, APHM, Aix Marseille Univ, INSERM, MMG, MarMaRa Institute, UMR 1251, La Conception University Hospital , 13385 Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Reynaud","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Endocrinology, CHU Timone Enfants, Assistance Publique-H\u00f4pitaux de Marseille (APHM) , 13385 Marseille ,","place":["France"]},{"name":"Aix Marseille University, INSERM, MMG, UMR 1251 , 13385 Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Saveanu","sequence":"additional","affiliation":[{"name":"Laboratory of Mol\u00e9cular Biology GenOp\u00e9, APHM, Aix Marseille Univ, INSERM, MMG, IUMR 1251, La Timone University Hospital , 13385 Marseille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Genhypopit Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Linglard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-S","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Daval Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Barat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nicolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Jullien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"issue":"4","key":"2025022114482275400_lvaf015-B1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ando.2024.03.001","article-title":"Position statement on the diagnosis and management of congenital pituitary deficiency in adults: the French National Diagnosis and Treatment Protocol (NDTP)","volume":"85","author":"Castets","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9","key":"2025022114482275400_lvaf015-B2","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1210\/jc.2005-2173","article-title":"Genetic screening of combined pituitary hormone deficiency: experience in 195 patients","volume":"91","author":"Reynaud","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2025022114482275400_lvaf015-B3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ebiom.2018.09.026","article-title":"Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: frequencies, phenotypes and growth outcomes","volume":"36","author":"Blum","year":"2018","journal-title":"EBioMedicine"},{"issue":"2","key":"2025022114482275400_lvaf015-B4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/cen.14355","article-title":"Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohort","volume":"94","author":"Jullien","year":"2021","journal-title":"Clin Endocrinol"},{"issue":"9","key":"2025022114482275400_lvaf015-B5","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.gim.2023.100881","article-title":"Identification of genetic variants and phenotypic characterization of a large cohort of patients with congenital hypopituitarism and related disorders","volume":"25","author":"Gregory","year":"2023","journal-title":"Genet Med"},{"issue":"6","key":"2025022114482275400_lvaf015-B6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/er.2016-1101","article-title":"Genetics of combined pituitary hormone deficiency: roadmap into the genome era","volume":"37","author":"Fang","year":"2016","journal-title":"Endocr Rev"},{"key":"2025022114482275400_lvaf015-B7","doi-asserted-by":"publisher","first-page":"1008306","DOI":"10.3389\/fendo.2022.1008306","article-title":"Novel genes and variants associated with congenital pituitary hormone deficiency in the era of next-generation sequencing","volume":"13","author":"Bando","year":"2022","journal-title":"Front Endocrinol"},{"issue":"3","key":"2025022114482275400_lvaf015-B8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41436-019-0666-z","article-title":"Diagnostic gene sequencing panels: from design to report\u2014a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Bean","year":"2020","journal-title":"Genet Med"},{"issue":"18","key":"2025022114482275400_lvaf015-B9","doi-asserted-by":"publisher","first-page":"9854","DOI":"10.3390\/ijms22189854","article-title":"The role of sonic hedgehog in human holoprosencephaly and short-rib polydactyly syndromes","volume":"22","author":"Loo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025022114482275400_lvaf015-B10","doi-asserted-by":"publisher","first-page":"1219018","DOI":"10.3389\/fendo.2023.1219018","article-title":"The hidden hedgehog of the pituitary: hedgehog signaling in development, adulthood and disease of the hypothalamic-pituitary axis","volume":"14","author":"Bian","year":"2023","journal-title":"Front Endocrinol"},{"issue":"3","key":"2025022114482275400_lvaf015-B11","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1530\/JME-15-0009","article-title":"Role of GLI2 in hypopituitarism phenotype","volume":"54","author":"Arnhold","year":"2015","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"2025022114482275400_lvaf015-B12","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/ajmg.a.62611","article-title":"Truncating and zinc-finger variants in GLI2 are associated with hypopituitarism","volume":"188","author":"Corder","year":"2022","journal-title":"Am J Med Genet A"},{"key":"2025022114482275400_lvaf015-B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ghir.2018.12.002","article-title":"A novel GLI2 mutation responsible for congenital hypopituitarism and polymalformation syndrome","volume":"44","author":"Mart\u00edn-Rivada","year":"2019","journal-title":"Growth Horm IGF Res"},{"issue":"9","key":"2025022114482275400_lvaf015-B14","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.3390\/ijms19092562","article-title":"Role of GLI transcription factors in pathogenesis and their potential as new therapeutic targets","volume":"19","author":"Sabol","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2025022114482275400_lvaf015-B15","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/humu.23038","article-title":"Mutational spectrum in holoprosencephaly shows that FGF is a new major signaling pathway: HUMAN MUTATION","volume":"37","author":"Dubourg","year":"2016","journal-title":"Hum Mutat"},{"issue":"23","key":"2025022114482275400_lvaf015-B16","doi-asserted-by":"publisher","first-page":"13424","DOI":"10.1073\/pnas.2235734100","article-title":"Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features","volume":"100","author":"Roessler","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"2025022114482275400_lvaf015-B17","doi-asserted-by":"publisher","first-page":"E384","DOI":"10.1210\/jc.2010-1050","article-title":"Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ectopic posterior pituitary lobe without holoprosencephaly","volume":"95","author":"Fran\u00e7a","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025022114482275400_lvaf015-B18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jmedgenet-2013-102249","article-title":"Pathogenic mutations in GLI2 cause a specific phenotype that is distinct from holoprosencephaly","volume":"51","author":"Bear","year":"2014","journal-title":"J Med Genet"},{"issue":"3","key":"2025022114482275400_lvaf015-B19","doi-asserted-by":"publisher","first-page":"E567","DOI":"10.1210\/jc.2012-3224","article-title":"Functional characterization of a heterozygous GLI2 missense mutation in patients with multiple pituitary hormone deficiency","volume":"98","author":"Flemming","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025022114482275400_lvaf015-B20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/cen.12565","article-title":"Sonic Hedgehog mutations are not a common cause of congenital hypopituitarism in the absence of complex midline cerebral defects","volume":"82","author":"Paulo","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"5","key":"2025022114482275400_lvaf015-B21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/cen.12637","article-title":"The role of the sonic hedgehog signalling pathway in patients with midline defects and congenital hypopituitarism","volume":"82","author":"Gregory","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2025022114482275400_lvaf015-B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000338706","article-title":"Genetic overlap between holoprosencephaly and Kallmann syndrome","volume":"3","author":"Vaaralahti","year":"2012","journal-title":"Mol Syndromol"},{"issue":"24","key":"2025022114482275400_lvaf015-B23","doi-asserted-by":"publisher","first-page":"e1.2","DOI":"10.1242\/dev.147652","article-title":"Gli2 gene-environment interactions contribute to the etiological complexity of holoprosencephaly: evidence from a mouse model","volume":"143","author":"Heyne","year":"2016","journal-title":"Development"},{"issue":"1","key":"2025022114482275400_lvaf015-B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/brain\/awy290","article-title":"Integrated clinical and omics approach to rare diseases: novel genes and oligogenic inheritance in holoprosencephaly","volume":"142","author":"Kim","year":"2019","journal-title":"Brain"},{"issue":"15","key":"2025022114482275400_lvaf015-B25","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/hmg\/ddi222","article-title":"A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2","volume":"14","author":"Roessler","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2025022114482275400_lvaf015-B26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ceb.2004.03.003","article-title":"Nonsense-mediated mRNA decay: terminating erroneous gene expression","volume":"16","author":"Baker","year":"2004","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"2025022114482275400_lvaf015-B27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"2025022114482275400_lvaf015-B28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41431-020-00755-z","article-title":"MobiDetails: online DNA variants interpretation","volume":"29","author":"Baux","year":"2021","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"2025022114482275400_lvaf015-B29","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1530\/EJE-19-0168","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: pituitary stalk interruption syndrome: etiology and clinical manifestations","volume":"181","author":"Vergier","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025022114482275400_lvaf015-B30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12020-011-9516-8","article-title":"Case seminar: a young female with acute hyponatremia and a sellar mass","volume":"40","author":"Pekic","year":"2011","journal-title":"Endocrine"},{"key":"2025022114482275400_lvaf015-B31","doi-asserted-by":"publisher","first-page":"1133492","DOI":"10.3389\/fendo.2023.1133492","article-title":"Case report: a case of Culler-Jones syndrome caused by a novel mutation of GLI2 gene and literature review","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol"},{"issue":"3","key":"2025022114482275400_lvaf015-B32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/cen.13914","article-title":"Novel GLI2 mutations identified in patients with combined pituitary hormone deficiency (CPHD): evidence for a pathogenic effect by functional characterization","volume":"90","author":"Babu","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2025022114482275400_lvaf015-B33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s13730-018-0302-9","article-title":"A novel heterozygous GLI2 mutation in a patient with congenital urethral stricture and renal hypoplasia\/dysplasia leading to end-stage renal failure","volume":"7","author":"Shirakawa","year":"2018","journal-title":"CEN Case Rep"},{"issue":"3","key":"2025022114482275400_lvaf015-B34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1530\/ERC-18-0538","article-title":"SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma","volume":"26","author":"Carreno","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2025022114482275400_lvaf015-B35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-016-0287-6","article-title":"Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles","volume":"4","author":"H\u00f6lsken","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2025022114482275400_lvaf015-B36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12964-018-0220-7","article-title":"A highlight on sonic hedgehog pathway","volume":"16","author":"Carballo","year":"2018","journal-title":"Cell Commun Signal"},{"key":"2025022114482275400_lvaf015-B37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ghir.2019.10.002","article-title":"Unique near-complete deletion of GLI2 in a patient with combined pituitary hormone deficiency and post-axial polydactyly","volume":"50","author":"Elizabeth","year":"2020","journal-title":"Growth Horm IGF Res"},{"issue":"7","key":"2025022114482275400_lvaf015-B38","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1210\/jc.2017-00332","article-title":"Digenic inheritance of PROKR2 and WDR11 mutations in pituitary stalk interruption syndrome","volume":"102","author":"McCormack","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025022114482275400_lvaf015-B39","doi-asserted-by":"publisher","first-page":"E1068","DOI":"10.1210\/jc.2011-3056","article-title":"PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption","volume":"97","author":"Reynaud","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2025022114482275400_lvaf015-B40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mce.2016.08.007","article-title":"Targeted next generation sequencing approach identifies eighteen new candidate genes in normosmic hypogonadotropic hypogonadism and Kallmann syndrome","volume":"437","author":"Quaynor","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"2025022114482275400_lvaf015-B41","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1515\/jpem-2020-0029","article-title":"A nonsense variant in FGFR1: a rare cause of combined pituitary hormone deficiency","volume":"33","author":"Erba\u015f","year":"2020","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf015\/61864547\/lvaf015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/2\/110\/61864547\/lvaf015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/2\/110\/61864547\/lvaf015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:49:09Z","timestamp":1740131349000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/2\/110\/8010719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf015","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,2,1]]}}}